📚 Lecture Overview
This lecture provides a comprehensive guide to hypothyroidism, covering its definitions, classifications, clinical presentations, and screening recommendations. It details the diagnostic workup process and outlines evidence-based treatment strategies using levothyroxine, including initiation, titration, and therapeutic targets.
🎯 Key Concepts & Definitions
- Primary Hypothyroidism: Defined as a high TSH with normal or low free T4.
- Overt Hypothyroidism (OH): Characterized by a high TSH and low free T4. All patients require treatment.
- Subclinical Hypothyroidism (SCH): Characterized by a high TSH with normal free T4. Further classified into mild (TSH < 10 µIU/L) and severe (TSH ≥ 10 µIU/L).
- Central Hypothyroidism (CH): A rare cause of hypothyroidism resulting from pituitary or hypothalamic disease, being about 1000-fold rarer than primary hypothyroidism.
- Steady State: Reached about 6 weeks (or 6 half-lives) after starting treatment or changing a levothyroxine dose, due to its 1-week plasma half-life.
📖 Main Content
Etiology and Epidemiology
- Major Causes: Hashimoto thyroiditis (autoimmune), iodine deficiency, congenital disorders, iatrogenic causes, and thyroiditis.
- Prevalence: Global prevalence varies, ranging from ~4.6% to 14% depending on the region (e.g., USA 4.6–8.9%, China 14%, India 11%).
- Demographics: Hypothyroidism is significantly more prevalent in females and increases with age.
Clinical Presentation
- Symptoms:
- Constipation
- Malaise and fatigue
- Hair fall
- Menstrual irregularities
- Cardiac dysrhythmia
- Change in skin texture
- Weight gain
- Signs: Can include characteristic physical findings and fluid retention, though overt hypothyroidism can occasionally be completely asymptomatic.
Screening Recommendations
- High-Risk Groups:
- Age 30+ years, obesity, and abnormal thyroid exams/goiters.
- Autoimmune diseases (Type 1 diabetes, Addison’s disease, pernicious anemia, vitiligo).
- Pregnancy-related history (infertility, 3+ pregnancies).
- History of partial thyroid surgery, radioiodine treatment, or head/neck irradiation.
- Personal or family history of thyroid dysfunction.
- Metabolic disorders (Type 2 diabetes, dyslipidemia).
- Medications: Amiodarone, lithium, interferon alpha, and tyrosine kinase inhibitors.
- Neuropsychiatric disorders (anxiety, depression, dementia) and chromosomal disorders (Down and Turner syndromes).
Laboratory Evaluation & Imaging
- Two-Step Approach:
- Step 1: Measure TSH.
- Step 2: Measure Free T4 if TSH is abnormal.
- Ultrasound: 90% of hypoechogenic glands result from autoimmune diseases (like Hashimoto's). The classic pattern features marked gland hypoechogenicity with hyperechogenic fibrotic tissue crossing the parenchyma.
Treatment Strategy: Levothyroxine (L-T4)
- Why Levothyroxine?: Favorable efficacy, long-term experience, good side effect profile, good intestinal absorption, long serum half-life, and low cost.
- Optimal Ingestion Timing:
- 1 hour before breakfast
- 3+ hours after last meal (at bedtime)
- Initiation Dosing:
- Overt hypothyroidism weight-based dose is typically around 1.4 µg/kg/day (adjusted for age and cardiac status).
- Subclinical hypothyroidism mild (mSCH) or severe (sSCH) use tailored weight-based algorithms.
- Lower initial doses (e.g., 25 µg/day) are used for older adults or patients with coronary heart disease (CHD).
- Titration & Pre-Titration Checks:
- Always check compliance, tablet ingestion timing, brand switches, proper storage, and recent illnesses before adjusting doses.
- Adjustments are typically made in increments of 12.5 µg to 25 µg.
📊 Visual Learning
flowchart TD
A[Measure TSH] --> B{Check TSH Value}
B -->|Normal| C[Euthyroid]
B -->|High| D[Measure Free T4]
D -->|Low Free T4| E[Overt Hypothyroidism]
D -->|Normal Free T4| F[Subclinical Hypothyroidism]
mindmap
root("Levothyroxine Intake")
"Optimal Timing"
"1 hour before breakfast"
"3 hours after last meal"
"Key Pharmacokinetics"
"1 week half life"
"6 weeks to steady state"
"Missed Doses"
"Make up missed doses"
graph LR
A[High TSH] --> B[Assess Free T4]
B --> C[Low: Overt Hypothyroidism]
B --> D[Normal: Subclinical Hypothyroidism]
C --> E[Always Treat]
D --> F[Evaluate Risk Factors and TSH Level]
💡 Important Points to Remember
- Primary hypothyroidism is defined by a high TSH and normal or low free T4.
- The plasma half-life of levothyroxine is 1 week, meaning a steady state takes 6 weeks to achieve.
- TSH levels should not be re-evaluated earlier than 6 weeks after starting therapy or modifying a dose.
- Optimal L-T4 intake is 1 hour before breakfast or 3+ hours after the last meal.
- All overt hypothyroidism patients must be treated.
- Not all subclinical hypothyroidism requires immediate treatment; management depends on TSH levels (e.g., cutoff of 10 µIU/L), age, and autoantibodies (anti-TPO).
- Obesity alone with high TSH and normal free T4 is not an indication for L-T4 treatment for weight loss.
- Common drugs causing hypothyroidism include amiodarone and lithium.
⚠️ Common Exam Questions
- The "Fat Loss vs. Fluid Loss" Trap: Examiners often ask if levothyroxine helps significant fat mass reduction in subclinical hypothyroidism or obesity. Trap: Choosing answers that state L-T4 causes major fat loss. Fact: Most initial weight changes are just retained fluids, not fat loss.
- Timing of Follow-up Labs: MCQs will test when to check TSH after a dose adjustment. Trap: Checking at 1 or 2 weeks. Fact: Must wait 6 weeks to reach a steady state.
- Subclinical vs. Overt Classification: Be prepared to classify a patient given specific TSH and Free T4 lab values.
📝 Quick Review Checklist
I can define and classify primary, overt, and subclinical hypothyroidism
I understand the two-step diagnostic lab approach (TSH then Free T4)
I know the optimal timing for taking levothyroxine
I understand why we must wait 6 weeks before checking TSH levels
I can outline who needs treatment for subclinical vs. overt hypothyroidism
I know how to interpret ultrasound findings in autoimmune thyroiditis